3Yip P,Chen TH,Seshaiah P,et al. Comprehensive serum profiling for the diseovery of epithelial ovarian cancer biomarkers [ J ]. PLoS One,2011,6 ( 12 ) :e29533.
4Nolen BM, Lokshin AE. Protein biomarkers of ovarian cancer: the forest and the trees[J]. Future Oncol,2012,8( 1 ) :55-71.
5Thakur A, Mishra V, Jain SK. Feed forward artificial neural net- work: tool for early detection of ovarian cancer [ J ]. Sci Pharm, 2011,79 (3) :493-505.
6Partheen K, Kristjansdottir B, Sundfeldt K. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a sus- picious cystic ovarian mass [ J ]. J Gynecol Oncol, 2011 , 22 ( 4 ) : 244-252.
7Van Gorp T, Cadron I, Despierre E, et al. HE4 and CA125 as a diag- nostic test in ovarian cancer: prospective validation of the Risk of O- varian Malignancy Algorithm [ J ]. Br J Cancer, 2011 , 104 ( 5 ) : 863 -870.
8Li F,Tie R,Chang K,et al. Does risk for ovarian malignancy algo- rithm excel human epididymis protein 4 and CA125 in predicting ep- ithelial ovarian cancer: a meta-analysis [ J ]. BMC Cancer, 2012, 12:258.
9Kalantri Y,Naik G,Joshi SP,et al. Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions[ Jl. Indi- an J Med Res,2007,125:25-30.
10Kalapotharakos G, Asciutto C, Henic E, et al. High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer[ J]. J Ovarian Res,2012,5(1):20.
